Bo Sun

No. 61 Jiefang West Road
Changsha, 410005, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Advances in Lipid Metabolism Reprogramming in Hepatocellular Carcinoma.

Advances in Lipid Metabolism Reprogramming in Hepatocellular Carcinoma.

Journal: Journal of clinical and translational hepatology

Published: January 15, 2026

Hypoxia-Induced ADAM8+ Macrophages and FAP+ Fibroblasts Form an Extracellular Matrix-Remodeling Niche at the Tumor Boundary in HCC.

Hypoxia-Induced ADAM8+ Macrophages and FAP+ Fibroblasts Form an Extracellular Matrix-Remodeling Niche at the Tumor Boundary in HCC.

Journal: Cancer immunology research

Published: October 07, 2025

Resection combined with hyperthermic intraperitoneal chemotherapy in the treatment of spontaneously ruptured hepatocellular carcinoma: a multicenter retrospective study.

Resection combined with hyperthermic intraperitoneal chemotherapy in the treatment of spontaneously ruptured hepatocellular carcinoma: a multicenter retrospective study.

Journal: Therapeutic advances in medical oncology

Published: September 04, 2025

Integration of Meta-Analysis and Network Pharmacology to Investigate the Pharmacological Mechanisms of Quercetin on Hepatocellular Carcinoma.

Integration of Meta-Analysis and Network Pharmacology to Investigate the Pharmacological Mechanisms of Quercetin on Hepatocellular Carcinoma.

Journal: Frontiers in bioscience (Landmark edition)

Published: September 03, 2025

HBV-driven expansion of CXCR6+-exhausted T cells and CXCL16+ macrophage interaction: Implications for immunotherapy in HCC.

HBV-driven expansion of CXCR6+-exhausted T cells and CXCL16+ macrophage interaction: Implications for immunotherapy in HCC.

Journal: Innovation (Cambridge (Mass.))

Published: August 31, 2025

CGR11 promotes hepatocellular carcinoma progression by regulating autophagy through the PI3K/AKT pathway.

CGR11 promotes hepatocellular carcinoma progression by regulating autophagy through the PI3K/AKT pathway.

Journal: Frontiers in cell and developmental biology

Published: August 25, 2025

Chinese multicenter expert consensus on the diagnosis and treatment of hilar cholangiocarcinoma: 2025 edition.

Chinese multicenter expert consensus on the diagnosis and treatment of hilar cholangiocarcinoma: 2025 edition.

Journal: Bioscience trends

Published: August 13, 2025

Scraping Hepatectomy Using Ultrasonic Scalpel for Complex Liver Segment Resection.

Scraping Hepatectomy Using Ultrasonic Scalpel for Complex Liver Segment Resection.

Journal: Annals of surgical oncology

Published: July 11, 2025

Drug repurposing: isosorbide mononitrate enhances tumor accumulation to augment sonodynamic therapy for hepatocellular carcinoma.

Drug repurposing: isosorbide mononitrate enhances tumor accumulation to augment sonodynamic therapy for hepatocellular carcinoma.

Journal: Journal of nanobiotechnology

Published: May 28, 2025

Research status of NIR-II fluorescent probe in liver cancer imaging.

Research status of NIR-II fluorescent probe in liver cancer imaging.

Journal: International journal of surgery (London, England)

Published: April 28, 2025

Research status of NIR-II fluorescent probe in liver cancer imaging.

Research status of NIR-II fluorescent probe in liver cancer imaging.

Journal: International journal of surgery (London, England)

Published: April 28, 2025

FDX1 downregulation activates mitophagy and the PI3K/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production.

FDX1 downregulation activates mitophagy and the PI3K/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production.

Journal: Redox biology

Published: April 02, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026